» Articles » PMID: 21768538

Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a

Abstract

Background: Upregulated by atheroprotective flow, the transcription factor Krüppel-like factor 2 (KLF2) is crucial for maintaining endothelial function. MicroRNAs (miRNAs) are noncoding small RNAs that regulate gene expression at the posttranscriptional level. We examined the role of miRNAs, particularly miR-92a, in the atheroprotective flow-regulated KLF2.

Methods And Results: Dicer knockdown increased the level of KLF2 mRNA in human umbilical vein endothelial cells, suggesting that KLF2 is regulated by miRNA. In silico analysis predicted that miR-92a could bind to the 3' untranslated region of KLF2 mRNA. Overexpression of miR-92a decreased the expression of KLF2 and the KLF2-regulated endothelial nitric oxide synthase and thrombomodulin at mRNA and protein levels. A complementary finding is that miR-92a inhibitor increased the mRNA and protein expression of KLF2, endothelial nitric oxide synthase, and thrombomodulin. Subsequent studies revealed that atheroprotective laminar flow downregulated the level of miR-92a precursor to induce KLF2, and the level of this flow-induced KLF2 was reduced by miR-92a precursor. Furthermore, miR-92a level was lower in human umbilical vein endothelial cells exposed to the atheroprotective pulsatile shear flow than under atheroprone oscillatory shear flow. Anti-Ago1/2 immunoprecipitation coupled with real-time polymerase chain reaction revealed that pulsatile shear flow decreased the functional targeting of miR-92a precursor/KLF2 mRNA in human umbilical vein endothelial cells. Consistent with these findings, mouse carotid arteries receiving miR-92a precursor exhibited impaired vasodilatory response to flow.

Conclusions: Atheroprotective flow patterns decrease the level of miR-92a, which in turn increases KLF2 expression to maintain endothelial homeostasis.

Citing Articles

Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.

Yang H, Li J, Song C, Li H, Luo Q, Chen M Int J Mol Sci. 2025; 26(4).

PMID: 40004206 PMC: 11855571. DOI: 10.3390/ijms26041743.


Epigenetic regulation in coronary artery disease: from mechanisms to emerging therapies.

Gao R, Liu M, Yang H, Shen Y, Xia N Front Mol Biosci. 2025; 12:1548355.

PMID: 39959304 PMC: 11825346. DOI: 10.3389/fmolb.2025.1548355.


Mechanosensory entities and functionality of endothelial cells.

Mierke C Front Cell Dev Biol. 2024; 12:1446452.

PMID: 39507419 PMC: 11538060. DOI: 10.3389/fcell.2024.1446452.


MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD.

Luo J, Wang L, Cui C, Chen H, Zeng W, Li X BMC Cardiovasc Disord. 2024; 24(1):394.

PMID: 39080547 PMC: 11287888. DOI: 10.1186/s12872-024-04063-y.


Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease.

Min L, Zhong F, Gu L, Lee K, He J Am J Physiol Cell Physiol. 2024; 327(2):C477-C486.

PMID: 38981608 PMC: 11901337. DOI: 10.1152/ajpcell.00222.2024.


References
1.
Atkins G, Jain M . Role of Krüppel-like transcription factors in endothelial biology. Circ Res. 2007; 100(12):1686-95. DOI: 10.1161/01.RES.0000267856.00713.0a. View

2.
Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T . Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004; 15(2):185-97. DOI: 10.1016/j.molcel.2004.07.007. View

3.
Bonauer A, Dimmeler S . The microRNA-17-92 cluster: still a miRacle?. Cell Cycle. 2009; 8(23):3866-73. DOI: 10.4161/cc.8.23.9994. View

4.
Nayak L, Lin Z, Jain M . "Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress. Antioxid Redox Signal. 2010; 15(5):1449-61. PMC: 3144441. DOI: 10.1089/ars.2010.3647. View

5.
Wang W, Ha C, Jhun B, Wong C, Jain M, Jin Z . Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS. Blood. 2010; 115(14):2971-9. PMC: 2854437. DOI: 10.1182/blood-2009-05-224824. View